56 results on '"Roger J. Watson"'
Search Results
2. Disruption of pocket protein dream complexes by E7 proteins of different types of human papillomaviruses
- Author
-
Roger J. Watson, Nurshamimi Nor Rashid, and Rohana Yusof
- Subjects
food.ingredient ,Papillomavirus E7 Proteins ,Plasma protein binding ,Alphapapillomavirus ,Biology ,Retinoblastoma Protein ,Risk category ,Tumor suppressor proteins ,food ,Virology ,Humans ,Tumor Suppressor Proteins ,Papillomavirus Infections ,Retinoblastoma protein ,virus diseases ,General Medicine ,female genital diseases and pregnancy complications ,In vitro ,Cell biology ,Infectious Diseases ,embryonic structures ,biology.protein ,biological phenomena, cell phenomena, and immunity ,Protein Binding - Abstract
It has been shown that the E7 protein of the high-risk HPV-16 transforms cells in vitro and binds pRB, p107 and p130, so called pocket proteins associated in cells with DREAM proteins, while that of the low-risk HPV-6 does not transform cells and binds p130 but not pRB or p107. These facts may indicate that p130 is essential for the HPV life cycle. To gain further insight into the relationship between HPV E7 proteins and pocket protein-DREAM complexes, E7 proteins of HPVs of various risk categories were expressed via appropriate vectors in T98G cells and the levels of various pocket proteins either total or associated with DREAM were analyzed. The obtained results demonstrated that high-risk HPV-16, HPV-18 and HPV-33, low-risk HPV-1 and HPV-11, and cutaneous HPV-48 disrupted pocket protein-DREAM complexes in T98G cells to a similar extent.
- Published
- 2013
3. HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block
- Author
-
Roger J. Watson, Nurshamimi Nor Rashid, Rohana Yusof, and Zi Ling Yong
- Subjects
Retinoblastoma like protein 2 (RBL2) ,0301 basic medicine ,Cell cycle checkpoint ,Pocket protein family ,Papillomavirus E7 Proteins ,Amino Acid Motifs ,Short Report ,Alphapapillomavirus ,Biology ,03 medical and health sciences ,0302 clinical medicine ,DREAM complex ,Virology ,Humans ,Protein Interaction Domains and Motifs ,Amino Acid Sequence ,E2F ,Human papillomavirus E7 oncoprotein ,S phase ,p130 ,Retinoblastoma-Like Protein p130 ,Papillomavirus Infections ,Cyclin-dependent kinase 2 ,Cell Cycle Checkpoints ,Cell cycle ,030104 developmental biology ,Infectious Diseases ,030220 oncology & carcinogenesis ,Mutation ,embryonic structures ,Cervical cancer ,biology.protein ,biological phenomena, cell phenomena, and immunity ,Protein Binding - Abstract
Background Retinoblastoma like protein 2 (RBL2) or p130 is a member of the pocket protein family, which is infrequently mutated in human tumours. Its expression is posttranscriptionally regulated and largely G0 restricted. We have previously shown that E6/E7 oncoproteins encoded by human papillomavirus (HPV) type 16, which is a high-risk type for cervical cancer development, must target p130 to promote the host cell to exit from quiescence (G0) state and enter S phase of the cell cycle. P130 is associated with the DREAM (DP, RB-like, E2F and MuvB) complex in G0/G1, which prevents S phase progression by repressing transcription of E2F-regulated genes. E7 proteins could potentially disrupt the p130-DREAM complex through two known mechanisms: direct interaction with p130 or induction of cyclin dependent kinase 2 (CDK2) phosphorylation by interacting with its inhibitor, p21CIP1. Methods In this study we have used p130 mutants deficient in binding the E7 LXCXE domain (p130mE7), unphosphorylatable by CDK2 (p130PM22) or a combination of both (p130PM22/mE7) to investigate these mechanisms used by E7 proteins to disrupt the p130-DREAM complex and promote cell cycle progression. Results We found that HPV16 E7 binding to p130 through its LXCXE domain was absolutely required to disrupt p130-DREAM to promote S phase of the cell cycle, as HPV16 E7 was unable to suppress p130mE7 but could suppress p130PM22. In contrast, the E7 protein encoded by a cutaneous HPV type that lacks a functional LXCXE domain, HPV 48 E7, was also able to disrupt p130-DREAM to promote cell cycling, but through the alternative mechanism. Thus, HPV48 E7 could suppress a cell cycle block imposed by p130mE7, but was unable to suppress p130PM22. Conclusions Overall, these results indicate that suppression of p130 is required for HPV-induced cell cycling, and that different HPV E7 proteins can use alternative mechanisms to achieve this. Electronic supplementary material The online version of this article (doi:10.1186/s12985-015-0460-8) contains supplementary material, which is available to authorized users.
- Published
- 2016
4. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication
- Author
-
Howard C. Thomas, Roger J. Watson, Peter Karayiannis, Fiona Tavner, and Saffie Jammeh
- Subjects
Hepatitis B virus ,HBsAg ,viruses ,Virus Replication ,medicine.disease_cause ,Virus ,Orthohepadnavirus ,Cell Line, Tumor ,Virology ,medicine ,Humans ,Hepatitis B e Antigens ,Nucleocapsid ,Promoter Regions, Genetic ,Mutation ,biology ,Hepatitis B ,biology.organism_classification ,Molecular biology ,digestive system diseases ,HBeAg ,Hepadnaviridae ,Viral replication ,Mutagenesis, Site-Directed - Abstract
There are two hypotheses explaining a fulminant outcome after hepatitis B virus (HBV) infection, both of which may be applicable at the same time: (i) basal core promoter (BCP) mutations increase viral replication, allowing rapid spread of the virus through the liver, and (ii) pre-core (pre-C) mutations abrogating hepatitis B e antigen (HBeAg) synthesis remove its tolerogenic effect, leading to a vigorous immune response. This study investigated the effect of these mutations on virus replication efficiency and HBeAg production. Substitutions A1762T/G1764A and T1753C, C1766T and T1768A in the BCP region, and G1896A and G1899A in the pre-C region, were examined either alone or in combination, using a common genetic background. Huh7 cells were transfected with these constructs and real-time PCR was used to quantify released virion-associated and intracellular HBV DNA, pregenomic RNA and pre-C mRNA. In addition, culture supernatants were tested for hepatitis B surface antigen (HBsAg) and HBeAg. The double BCP mutation (A1762T/G1764A) and the pre-C mutations (G1896A, G1899A), either alone or in combination, had no appreciable effect on the replication capacity of the virus. In contrast, clones with mutations at positions 1766/1768, 1762/1764/1766 and 1753/1762/1764 exhibited increased-replication phenotypes. HBeAg was undetectable in all cultures transfected with constructs bearing the G1896A stop-codon mutation, as expected. In contrast, constructs with additional mutations in the BCP region had appreciably lower levels of HBeAg expression than the wild type. Thus, core promoter mutations other than those at 1762/1764 appear to upregulate viral DNA replication and, at the same time, greatly reduce HBeAg production.
- Published
- 2008
5. p27Kip1 and p130 Cooperate To Regulate Hematopoietic Cell Proliferation In Vivo
- Author
-
Janet Glassford, Nicholas Lea, David J. Mann, Emma S. Child, Eric Lam, Kikkeri N. Naresh, Hanna M. Romanska, Stephen J. Orr, Claudia Roberts, Azim M Mohamedali, Inês Soeiro, El-Nasir Lalani, N. Shaun B. Thomas, and Roger J. Watson
- Subjects
Myeloid ,CD3 Complex ,Hematopoietic System ,CD3 ,Thymus Gland ,Biology ,Mice ,In vivo ,TheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITY ,medicine ,Animals ,Molecular Biology ,Cells, Cultured ,Cell Proliferation ,Mice, Knockout ,B-Lymphocytes ,Retinoblastoma-Like Protein p130 ,Cell growth ,Cell Cycle ,Cyclin-Dependent Kinase 2 ,Cyclin-dependent kinase 2 ,Articles ,Cell Biology ,Cell cycle ,In vitro ,Up-Regulation ,Cell biology ,Haematopoiesis ,medicine.anatomical_structure ,embryonic structures ,Blood Group Antigens ,biology.protein ,Leukocyte Common Antigens ,biological phenomena, cell phenomena, and immunity ,Cyclin-Dependent Kinase Inhibitor p27 ,Spleen ,Protein Binding - Abstract
To investigate the potential functional cooperation between p27Kip1 and p130 in vivo, we generated mice deficient for both p27Kip1 and p130. In p27Kip1-/-; p130-/- mice, the cellularity of the spleens but not the thymi is significantly increased compared with that of their p27Kip1-/- counterparts, affecting the lymphoid, erythroid, and myeloid compartments. In vivo cell proliferation is significantly augmented in the B and T cells, monocytes, macrophages, and erythroid progenitors in the spleens of p27Kip1-/-; p130-/- animals. Immunoprecipitation and immunodepletion studies indicate that p130 can compensate for the absence of p27Kip1 in binding to and repressing CDK2 and is the predominant CDK-inhibitor associated with the inactive CDK2 in the p27Kip1-/- splenocytes. The finding that the p27Kip1-/-; p130-/- splenic B cells are hypersensitive to mitogenic stimulations in vitro lends support to the concept that the hyperproliferation of splenocytes is not a result of the influence of their microenvironment. In summary, our findings provide genetic and molecular evidence to show that p130 is a bona fide cyclin-dependent kinase inhibitor and cooperates with p27Kip1 to regulate hematopoietic cell proliferation in vivo.
- Published
- 2006
6. A B-myb--DREAM complex is not critical to regulate the G2/M genes in HPV-transformed cell lines
- Author
-
Nurshamimi Nor, Rashid, Rohana, Yusof, and Roger J, Watson
- Subjects
G2 Phase ,Human papillomavirus 16 ,Reverse Transcriptase Polymerase Chain Reaction ,Papillomavirus E7 Proteins ,Blotting, Western ,Papillomavirus Infections ,Uterine Cervical Neoplasms ,Cell Cycle Proteins ,Kv Channel-Interacting Proteins ,Cell Transformation, Viral ,Flow Cytometry ,Real-Time Polymerase Chain Reaction ,Gene Expression Regulation, Neoplastic ,Genes, cdc ,Repressor Proteins ,Trans-Activators ,Tumor Cells, Cultured ,Humans ,Immunoprecipitation ,Female ,RNA, Messenger ,Glioblastoma ,Cell Division ,Cell Proliferation - Abstract
It is well-established that HPV E7 proteins, encoded by human papillomavirus (HPV) genes, frequently associated with cervical cancers bind avidly to the retinoblastoma (RB) family of pocket proteins and disrupt their association with members of the E2F transcription factor family. Our previous study showed that the repressive p130-dimerization partner, RB-like, E2F and multi-vulval class (DREAM) complex was disrupted by HPV16 E7 proteins in order to maintain the viral replication in CaSki cells. However, we would like to address whether the activator B-myb-DREAM complex is critical in regulating the replication and mitosis phase since our previous study showed increased B-myb-DREAM expression in HPV-transformed cell lines when compared to control cells.The association of B-myb with both LIN-54 and LIN-9 was equally decreased by depleting LIN-54 in CaSki cells. Flow cytometry analysis showed that LIN-54 depletion caused an increased proportion of G2/M cells in T98G, SiHa and CaSki cells. The mRNA levels of certain S/G2 genes such as cyclin B, aurora kinase A and Polo-like kinase 1 have demonstrated a marginal increased in CaSki-Lin-54-depleted cells when compared to SiHa- and T98G-Lin-54-depleted cells. We further confirmed this experiment by depleting the B-myb itself in CaSki cells and the results showed the same pattern of cell cycle and mRNA levels for S/G2 genes when compared to LIN-54- and LIN-9-depleted cells.The B-myb-DREAM complex might not be vital for progression through mitosis in cells lacking a G1/S checkpoint and not as crucial as the p130-DREAM complex for the survival of the HPV virus.
- Published
- 2014
7. Generation of a conditional allele of the B-myb gene
- Author
-
Oscar Berlanga, Paloma Garcia, Roger J. Watson, and Jon Frampton
- Subjects
DNA Replication ,Genotype ,Transgene ,Cell Cycle Proteins ,Biology ,Mice ,Endocrinology ,Gene expression ,Genetics ,Animals ,Allele ,Gene ,Transcription factor ,Alleles ,Cells, Cultured ,Crosses, Genetic ,Cell Proliferation ,Mice, Knockout ,Recombination, Genetic ,Homozygote ,fungi ,Intron ,Cell Biology ,Cell cycle ,Molecular biology ,Introns ,Cre-Lox recombination ,Transcription Factors - Abstract
B-Myb is an essential transcription factor involved in control of the cell cycle and the regulation of tissue-specific gene expression in a wide range of cell types. Loss of both alleles results in early embryonic lethality at E4.5–6.5. To address the function of B-Myb in later stages of embryogenesis and in specific adult tissues, a floxed B-myb allele (B-mybF) was generated. Cre-mediated deletion in vivo was demonstrated by breeding with a transgenic GATA-Cre mouse line. An intermediate allele produced in the creation of the floxed allele, in which the PGK-neoR cassette is present in intron 3 (B-mybloxneo), was deduced to be a weak hypomorph based on the later embryonic death of homozygotes compared to B-myb−/− embryos. To demonstrate the efficiency and possible consequences of B-myb inactivation, we performed conditional deletion in cultured MEFs and observed decreased growth that correlated with aberrant nuclear DNA replication. genesis 43:189–195, 2005. © 2005 Wiley-Liss, Inc.
- Published
- 2005
8. The Cell Cycle-regulated B-Myb Transcription Factor Overcomes Cyclin-dependent Kinase Inhibitory Activity of p57 by Interacting with Its Cyclin-binding Domain
- Author
-
Roger J. Watson and Manel Joaquin
- Subjects
Cyclin binding ,biology ,Cyclin D ,Cyclin A ,Cyclin-dependent kinase 2 ,Cyclin-dependent kinase 3 ,Cell Biology ,Biochemistry ,Molecular biology ,Cell biology ,Cyclin-dependent kinase ,biology.protein ,Cyclin-dependent kinase complex ,biological phenomena, cell phenomena, and immunity ,Molecular Biology ,Cyclin A2 - Abstract
The cell cycle-regulated B-Myb transcription factor is required for early embryonic development and is implicated in regulating cell growth and differentiation. In addition to its transcriptional regulatory properties, recent data indicate that B-Myb can release active cyclin/Cdk2 activity from the retinoblastoma-related p107 protein by directly interacting with the p107 N terminus. As this p107 domain has homology to the cyclin-binding domains of the p21Waf1/Cip1 family of cyclin-dependent kinase inhibitors (CKIs), we investigated in this study whether B-Myb could also interact with these CKIs. No in vivo interaction was found with either p21Waf1/Cip1 or p27 KIP1 , however, binding to p57 KIP2 was readily detectable in both in vivo and in vitro assays. The B-Myb-interacting region of p57 KIP2 mapped to the cyclin-binding domain. Consistent with this, B-Myb competed with cyclin A2 for binding to p57 KIP2 , resulting in release of active cyclin/Cdk2 kinase. Moreover, B-Myb partially overcame the ability of p57 KIP2 to induce G1 arrest in Saos-2 cells. Despite similarities with previous p107 studies, the B-Myb domains required for interaction with p57 KIP2 were quite different from those implicated for p107. Thus, it is evident that B-Myb may promote cell proliferation by a non-transcriptional mechanism that involves release of active cyclin/Cdk2 from p57 KIP2 as well as p107.
- Published
- 2003
9. B-Myb protein in cellular proliferation, transcription control, and cancer: Latest developments
- Author
-
Arturo Sala and Roger J. Watson
- Subjects
Cell type ,animal structures ,Physiology ,Cell growth ,fungi ,Clinical Biochemistry ,Cancer ,Cell Biology ,Biology ,Cell cycle ,medicine.disease ,Cell biology ,Cycle control ,medicine ,Transcription control ,Transcription factor ,B-MYB Protein - Abstract
Since its isolation exactly a decade ago, B-Myb has intrigued a growing number of scientists interested in understanding the mechanisms of cell proliferation. In many aspects the B-Myb story resembles that of a fashionable transcription factor involved in cell cycle control: E2F-1. Similar to E2F-1, B-Myb is a transcription factor whose expression is regulated at the G1/S border of the cell cycle. Given the ubiquitous expression of B-Myb within different cell types, its link with the cell cycle, and augmented expression in transformed cells, studies are in progress to define the potential role of B-Myb in human cancer. The purpose of this review is not to provide an extensive background to the B-Myb field but rather to describe the latest developments. A comprehensive outline of B-Myb structure and function can be found in the review by Saville and Watson (1998a, Adv. Cancer Res., 72:109-140).
- Published
- 1999
10. B-MYB transactivates its own promoter through SP1-binding sites
- Author
-
Arturo Sala, Maria Neve Cervellera, I Casella, Cesare Peschle, Robert E. Lewis, P. De Luca, Biagio Saitta, and Roger J. Watson
- Subjects
Transcriptional Activation ,Cancer Research ,Saccharomyces cerevisiae Proteins ,animal structures ,Transcription, Genetic ,Sp1 Transcription Factor ,Recombinant Fusion Proteins ,Oligonucleotides ,Cell Cycle Proteins ,Biology ,Transfection ,Cell Line ,Fungal Proteins ,Proto-Oncogene Proteins c-myb ,Transactivation ,Sp3 transcription factor ,Transcription (biology) ,Proto-Oncogene Proteins ,Coactivator ,Genetics ,Humans ,MYB ,Promoter Regions, Genetic ,Molecular Biology ,Sp1 transcription factor ,Binding Sites ,fungi ,NF-kappa B ,Herpes Simplex Virus Protein Vmw65 ,Fusion protein ,Molecular biology ,DNA-Binding Proteins ,Sp3 Transcription Factor ,Trans-Activators ,Adenovirus E1A Proteins ,Protein Binding ,Transcription Factors - Abstract
B-MYB is an ubiquitous protein required for mammalian cell growth. In this report we show that B-MYB transactivates its own promoter through a 120 bp segment proximal to the transcription start site. The B-MYB-responsive element does not contain myb-binding sites and gel-shift analysis shows that SP1, but not B-MYB, protein contained in SAOS2 cell extracts binds to the 120 bp B-myb promoter fragment. B-MYB-dependent transactivation is cooperatively increased in the presence of SP1, but not SP3 overexpression. When the SP1 elements of the B-myb promoter are transferred in front of a heterologous promoter, an increased response to B-MYB results. In contrast, c-MYB, the prototype member of the Myb family, is not able to activate the luciferase construct containing the SP1 elements. With the use of an SP1-GAL4 fusion protein, we have determined that the cooperative activation occurs through the domain A of SP1. These observations suggest that B-MYB functions as a coactivator of SP1, and that diverse combinations of myb and SP1 sites may dictate the responsiveness of myb-target genes to the various members of the myb family.
- Published
- 1999
11. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation
- Author
-
Sarah Lane, Roger J. Watson, and Peter Farlie
- Subjects
Transcriptional Activation ,Cancer Research ,animal structures ,Cyclin A ,Cell Cycle Proteins ,Transfection ,Mice ,Transactivation ,Cyclin-dependent kinase ,Tumor Cells, Cultured ,Genetics ,Animals ,Humans ,MYB ,Phosphorylation ,Molecular Biology ,Conserved Sequence ,Cyclin ,biology ,Kinase ,Cell Cycle ,Cyclin-dependent kinase 2 ,3T3 Cells ,Cell cycle ,Molecular biology ,DNA-Binding Proteins ,Trans-Activators ,biology.protein ,Protein Kinases ,Transcription Factors - Abstract
Transcription of the B-Myb gene is cell cycle regulated by an E2F-dependent mechanism and its product, B-Myb, is itself a transcription factor required for S-phase entry. Previously, we have shown that B-Myb is specifically phosphorylated during S-phase and that similar modification to a less electrophoretically mobile form could be induced by baculovirus-expressed cyclin A/Cdk2 kinase. We report here that cyclin A-mediated phosphorylation of B-Myb is associated with a marked increase in transactivation function in U-2 OS cells. In contrast to previous studies, transactivation of the luciferase reporter was dependent upon Myb binding sites located upstream of the promoter. Enhancement of B-Myb activation function was also obtained by truncation of the C-terminus just downstream of a domain conserved in evolution. Potentiation of B-Myb activity by phosphorylation was not simply a consequence of overcoming the negative effect of the C-terminus, however, as the truncated protein was to a lesser extent also activated by cyclin A/Cdk2. Whereas wild-type B-Myb transactivation activity could not be potentiated by cyclin A/Cdk2 in NIH3T3 cells, the truncated protein was hyperactive. Finally, we showed that B-Myb synergises with cyclin A to promote U-2 OS cells into S-phase.
- Published
- 1997
12. Conditional inhibition of erythroid differentiation by c-Myb/oestrogen receptor fusion proteins
- Author
-
Jonathan J. Lyon and Roger J. Watson
- Subjects
Transcriptional Activation ,Cancer Research ,animal structures ,Recombinant Fusion Proteins ,Cellular differentiation ,Biology ,Mice ,Proto-Oncogene Proteins c-myb ,Transactivation ,Proto-Oncogene Proteins ,hemic and lymphatic diseases ,Animals ,Dimethyl Sulfoxide ,MYB ,Molecular Biology ,Transcription factor ,Erythroid-Specific DNA-Binding Factors ,Cell growth ,fungi ,Cell Differentiation ,3T3 Cells ,Cell Biology ,Molecular biology ,Fusion protein ,DNA-Binding Proteins ,Receptors, Estrogen ,Leukemia, Erythroblastic, Acute ,Cell Division ,Transcription Factors ,Developmental Biology - Abstract
The c-myb proto-oncogene encodes a transcription factor that has been implicated in the regulation of haemopoietic cell differentiation and appears also to be required for cell proliferation in a number of different lineages. Typically, transcription of c-myb is down-regulated during haemopoietic cell differentiation, and it has been found in several erythroid and myeloid cell lines that constitutive c-myb expression, from a transfected plasmid, blocks this differentiation process. To investigate further the activity of c-myb in haemopoietic cell differentiation, we have transfected Friend murine erythroleukaemia (F-MEL) cells with plasmids encoding conditionally active c-Myb/oestrogen receptor (Myb/ER) fusion proteins. Transcriptional activity of the Myb/ER fusion proteins was found to be strictly hormone-dependent, and this property was correlated with the ability of these proteins to inhibit erythroid differentiation. From analysis of a Myb/ER protein that lacks the c-Myb transactivation domain, it was apparent that the C-terminal ER transactivation domain could substitute for that of c-Myb in inhibition of differentiation. Activation of Myb/ER in F-MEL cells had no effect upon the early and transient inhibition of entry into S phase associated with dimethyl sulfoxide (DMSO) induction. Further analyses of α-globin and PU.1 gene transcription suggested that c-Myb is unable to influence gene expression immediately following DMSO-induction and that inhibition of F-MEL cell differentiation must therefore result from the function of c-Myb in the post-commitment period. Nonetheless, c-Myb had effects on the erythroid differentiation programme that were clearly dissociated from its role in cell proliferation. The potential use of this system to identify c-Myb target genes involved in F-MEL cell differentiation is discussed.
- Published
- 1995
13. The Role of Myb Proteins in Normal and Neoplastic Cell Proliferation
- Author
-
Jonathan J. Lyon, Cleo Robinson, and Roger J. Watson
- Subjects
Transcriptional Activation ,Cancer Research ,Cell type ,animal structures ,Cell growth ,Cell Cycle ,fungi ,Cell cycle ,Biology ,Cell biology ,Proto-Oncogene Proteins c-myb ,Transcription Regulatory Protein ,Gene Expression Regulation ,Neoplasms ,Proto-Oncogene Proteins ,Cancer research ,Animals ,Humans ,Neoplastic cell ,MYB ,E2F ,Transcription factor ,Cell Division - Abstract
The c-myb protooncogene is the prototype of a gene family that contains two other recently described members, A-myb and B-myb. The c-myb gene encodes a transcription regulatory protein, c-Myb, that has distinct DNA-binding domain structure and binding specificity compared with unrelated transcription factors. All three members of the myb protein family, however, display a high degree of homology within their DNA-binding domain, suggesting that they may regulate transcription of a similar set of target genes. We examine here whether, by implication, the individual members of the myb gene family play analogous roles within the cell, in particular focusing on their potential functions in the control of cell proliferation. Expression of both c-myb and B-myb is subject to regulation in the cell cycle, transcripts of these genes being induced within the G1 phase of the cell cycle and persisting at maximal levels through S phase. Consistent with this timing of expression, inhibition of c-Myb and B-Myb synthesis by treatment of cells with anti-sense oligonucleotides indicates that both proteins are required for transition from the G1 to S phase of the cell cycle. The c-Myb and B-Myb proteins cannot be considered as analogs, however, as they show certain differences in trans-activation activity of their target genes. Moreover, while superficially similar, expression of c-myb and B-myb is not coordinated, and it is conceivable that their products have quite distinct functions in the regulation of cell proliferation. The ubiquitous expression of B-myb in cycling cells and its strict regulation during late G1 suggest a universal function for B-Myb in G1 to S phase transition. Consistent with this conclusion, B-myb transcription is controlled by the transcription factor E2F, which has been implicated in cell cycle regulation of a number of genes involved in DNA synthesis. The restricted tissue tropism of c-myb expression and its regulation by certain growth factors such as IL-2 suggest a specific function in transduction of extrinsic proliferation (and differentiation) signals. The role of A-myb in the cell remains to be determined; however, its expression shows no correlation with cell cycling, implying that it has no direct role in cell proliferation. Recent data show that the necessity for c-myb function in proliferation of a number of cell types provides a promising opportunity for intervention in the treatment of certain tumors.
- Published
- 1994
14. Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb
- Author
-
Julie Millour, Christin F. Down, Eric Lam, and Roger J. Watson
- Subjects
Transcriptional Activation ,animal structures ,Response element ,Biophysics ,Mitosis ,Cell Cycle Proteins ,Biology ,Protein Serine-Threonine Kinases ,Biochemistry ,Mice ,Structural Biology ,Transcription (biology) ,Proto-Oncogene Proteins ,Genetics ,Animals ,MYB ,Phosphorylation ,Promoter Regions, Genetic ,Molecular Biology ,Transcription factor ,Gene ,Mice, Knockout ,Binding Sites ,Pioneer factor ,Forkhead Box Protein M1 ,Promoter ,Forkhead Transcription Factors ,3T3 Cells ,Molecular biology ,Cyclin-Dependent Kinases ,G2 Phase Cell Cycle Checkpoints ,Gene Expression Regulation ,Trans-Activators ,Chromatin immunoprecipitation ,Protein Binding ,Transcription Factors - Abstract
The promoters of genes which regulate entry into and progress through mitosis are typically induced maximally in G2 by transcription factors that include B-Myb and FoxM1. As FoxM1 gene transcription is a target of B-Myb, we investigated in this study how these transcription factors functionally interact to regulate these G2/M genes. Using a 3T3 cell line containing floxed B-myb alleles (B-myb(F/F)) that could be conditionally deleted by Cre recombinase, we confirmed that B-myb knockout caused both decreased mRNA expression of several G2/M genes, including FoxM1, and delayed entry into mitosis. Although FoxM1 protein expression was actually unaffected by B-myb knockout when quiescent B-myb(F/F) 3T3 cells re-entered the cell cycle upon serum-stimulation, chromatin immunoprecipitation revealed that FoxM1 binding to G2/M promoters was substantially reduced. FoxM1 transcriptional activity requires sequential phosphorylation by Cyclin-dependent kinases and Plk1, which are B-Myb target genes, and we found that phosphorylation at Plk1-specific sites was somewhat reduced upon B-myb knockout. Neither this effect nor nuclear accumulation of FoxM1, which was unaffected by B-myb knockout, was sufficient to account for the dependence on B-Myb for FoxM1 promoter binding, however. More significantly, assays using paired Birc5 (survivin) promoter-luciferase reporters with either wild-type or mutated Myb binding sites showed that FoxM1 was unable to bind and activate the promoter in the absence of B-Myb binding. Our data suggest that B-Myb is required as a pioneer factor to enable FoxM1 binding to G2/M gene promoters and explains how these transcription factors may collaborate to induce mitosis.
- Published
- 2011
15. Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells
- Author
-
Roger J. Watson, Rohana Yusof, and Nurshamimi Nor Rashid
- Subjects
Papillomavirus E7 Proteins ,Cell ,Biology ,Malignant transformation ,Virology ,Cell Line, Tumor ,medicine ,Humans ,DREAM complex ,Transcription factor ,E2F4 ,Cell Proliferation ,Human papillomavirus 16 ,Cell growth ,Cell Cycle ,Epithelial Cells ,Kv Channel-Interacting Proteins ,Oncogene Proteins, Viral ,Cell cycle ,humanities ,Repressor Proteins ,medicine.anatomical_structure ,Crk-Associated Substrate Protein ,Cell culture ,embryonic structures ,Host-Pathogen Interactions ,biological phenomena, cell phenomena, and immunity ,Protein Multimerization - Abstract
Human papillomaviruses (HPVs) with tropism for mucosal epithelia are the major aetiological factors in cervical cancer. Most cancers are associated with so-called high-risk HPV types, in particular HPV16, and constitutive expression of the HPV16 E6 and E7 oncoproteins is critical for malignant transformation in infected keratinocytes. E6 and E7 bind to and inactivate the cellular tumour suppressors p53 and Rb, respectively, thus delaying differentiation and inducing proliferation in suprabasal keratinocytes to enable HPV replication. One member of the Rb family, p130, appears to be a particularly important target for E7 in promoting S-phase entry. Recent evidence indicates that p130 regulates cell-cycle progression as part of a large protein complex termed DREAM. The composition of DREAM is cell cycle-regulated, associating with E2F4 and p130 in G0/G1 and with the B-myb transcription factor in S/G2. In this study, we addressed whether p130–DREAM is disrupted in HPV16-transformed cervical cancer cells and whether this is a critical function for E6/E7. We found that p130–DREAM was greatly diminished in HPV16-transformed cervical carcinoma cells (CaSki and SiHa) compared with control cell lines; however, when E6/E7 expression was targeted by specific small hairpin RNAs, p130–DREAM was reformed and the cell cycle was arrested. We further demonstrated that the profound G1 arrest in E7-depleted CaSki cells was dependent on p130–DREAM reformation by also targeting the expression of the DREAM component Lin-54 and p130. The results show that continued HPV16 E6/E7 expression is necessary in cervical cancer cells to prevent cell-cycle arrest by a repressive p130–DREAM complex.
- Published
- 2011
16. A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells
- Author
-
Roger J. Watson, A S Knight, and M Notaridou
- Subjects
G2 Phase ,Transcriptional Activation ,Cancer Research ,Chromatin Immunoprecipitation ,Embryonal Carcinoma Stem Cells ,LINC complex ,Survivin ,Cyclin B ,Cell Cycle Proteins ,Inhibitor of Apoptosis Proteins ,Mice ,Genetics ,Animals ,DREAM complex ,Cyclin B1 ,Promoter Regions, Genetic ,Molecular Biology ,Transcription factor ,Mitosis ,E2F4 ,Binding Sites ,biology ,Tumor Suppressor Proteins ,fungi ,Cell biology ,E2F Transcription Factors ,Repressor Proteins ,biology.protein ,Trans-Activators ,Microtubule-Associated Proteins ,Cell Division - Abstract
It has recently been discovered that cell-cycle gene transcription is regulated by a core complex named LINC that switches from a transcriptionally repressive complex in G(0)-G(1) with the p130 or p107 pocket proteins and E2F4 to a transcriptionally active complex in S-G(2) containing B-Myb. We have studied the function of LINC in F9 embryonal carcinoma cells, which are distinguished by a rapid cell cycle resulting from an extremely short G(1) phase. We show that suppressing expression of the LINC component, Lin-9, in F9 cells causes arrest in mitosis, and we have used this system to screen for transcriptional targets. In these cells, B-Myb was found in complexes with Lin-9 and several other LINC constituents, however, the pocket proteins did not associate with LINC unless F9 cells were differentiated. Lin-9 and B-Myb were both required for transcription of G(2)/M genes such as Cyclin B1 and Survivin. Moreover, B-Myb was demonstrated to recruit Lin-9 to the Survivin promoter through multiple Myb-binding sites. The demonstration that a B-Myb/LINC complex is vital for progression through mitosis in cells lacking a G(1)/S checkpoint has implications for both undifferentiated embryonal cells and for cancers in which pocket protein function is compromised.
- Published
- 2009
17. Nucleotide preferences in sequence-specific recognition of DNA by c-mybprotein
- Author
-
Roger J. Watson and Kathy Howe
- Subjects
animal structures ,Molecular Sequence Data ,Cell Cycle Proteins ,Biology ,Mice ,Proto-Oncogene Proteins c-myb ,chemistry.chemical_compound ,Proto-Oncogene Proteins ,Consensus Sequence ,Genetics ,Consensus sequence ,Animals ,MYB ,Nucleotide ,Amino Acid Sequence ,Binding site ,Gene ,chemistry.chemical_classification ,Binding Sites ,Base Sequence ,Oligonucleotide ,DNA ,DNA-Binding Proteins ,chemistry ,Trans-Activators ,Transcription Factors - Abstract
Using a binding site selection procedure, we have found that sequence-specific DNA-binding by the mouse c-myb protein involves recognition of nucleotides outside of the previously identified hexanucleotide motif. Oligonucleotides containing a random nucleotide core were immunoprecipitated in association with c-Myb, amplified by the Polymerase Chain Reaction and cloned in plasmids prior to sequencing. By alignment of sequences it was apparent that additional preferences existed at each of three bases immediately 5' of the hexanucleotide consensus, allowing an extension of the preferred binding site to YGRCVGTTR. The contributions of these 5' nucleotides to binding affinity was established in bandshift analyses with oligonucleotides containing single base substitutions; in particular, it was found that replacement of the preferred guanine at position -2 with any other base greatly reduced c-Myb binding. We found that the protein encoded by the related B-myb gene bound the preferred c-Myb site with similar affinity; however, B-Myb and c-Myb showed distinct preferences for the identity of the nucleotide at position -1 relative to the hexanucleotide consensus. This study demonstrates that the c-Myb DNA-binding site is more extensive than recognised hitherto and points to similar but distinct nucleotide preferences in recognition of DNA by related Myb proteins.
- Published
- 1991
18. B-Myb: A Highly Regulated Member Of The Myb Transcription Factor Family
- Author
-
Roger J. Watson
- Subjects
Transactivation ,Phosphorylation sites ,Chemistry ,MYB ,Cell cycle ,Transcription factor ,Cell biology - Published
- 2007
19. Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells
- Author
-
Jon Frampton, Fiona Tavner, and Roger J. Watson
- Subjects
Cancer Research ,Chromatin Immunoprecipitation ,Transcription, Genetic ,Mutant ,Blotting, Western ,DNA Footprinting ,Mitosis ,Cell Cycle Proteins ,Biology ,Histone H3 ,Mice ,Genetics ,Gene silencing ,Animals ,Gene Silencing ,RNA, Messenger ,E2F ,Promoter Regions, Genetic ,Molecular Biology ,Transcription factor ,Cells, Cultured ,Regulation of gene expression ,Mice, Knockout ,Binding Sites ,Reverse Transcriptase Polymerase Chain Reaction ,Cell Cycle ,Cell cycle ,Fibroblasts ,Embryo, Mammalian ,Flow Cytometry ,Molecular biology ,E2F Transcription Factors ,DNA-Binding Proteins ,Gene Expression Regulation ,Mutation ,Trans-Activators ,Chromatin immunoprecipitation - Abstract
Previous studies have shown that the cell cycle-regulated B-myb promoter contains a conserved E2F binding site that is critical for repressing transcription in quiescent cells. To investigate its significance for permanent promoter silencing, we have inactivated this binding site in the mouse genome. Mice homozygous for the mutant B-mybmE2F allele were fully viable, however, B-myb transcription was derepressed during quiescence in mouse embryo fibroblasts (MEFs) derived from mutant animals. Moreover, it was found that mutation of the E2F site resulted in abnormal maintenance of B-myb expression in senescent MEFs and in differentiated brain tissue. These findings therefore reveal a direct and primary role for repressive E2F complexes in silencing gene expression in post-mitotic cells. Analysis of histone modifications at the promoter showed that histone H3 lysine 9 was constitutively acetylated throughout the cell cycle in homozygous mutant MEFs. This mouse system is the first description of an E2F site mutation in situ and will facilitate the study of E2F function in vivo.
- Published
- 2006
20. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain
- Author
-
Manel, Joaquin and Roger J, Watson
- Subjects
Transcriptional Activation ,Recombinant Fusion Proteins ,Blotting, Western ,Molecular Sequence Data ,Cell Cycle Proteins ,Retinoblastoma-Like Protein p107 ,Cyclin A ,Binding, Competitive ,Structure-Activity Relationship ,Cyclins ,CDC2-CDC28 Kinases ,Tumor Cells, Cultured ,Humans ,Amino Acid Sequence ,Enzyme Inhibitors ,Cyclin-Dependent Kinase Inhibitor p57 ,Glutathione Transferase ,Osteosarcoma ,Binding Sites ,Cyclin-Dependent Kinase 2 ,G1 Phase ,Nuclear Proteins ,Cyclin-Dependent Kinases ,Peptide Fragments ,DNA-Binding Proteins ,Mutagenesis, Site-Directed ,Trans-Activators ,Cyclin A2 ,Cell Division ,Gene Deletion - Abstract
The cell cycle-regulated B-Myb transcription factor is required for early embryonic development and is implicated in regulating cell growth and differentiation. In addition to its transcriptional regulatory properties, recent data indicate that B-Myb can release active cyclin/Cdk2 activity from the retinoblastoma-related p107 protein by directly interacting with the p107 N terminus. As this p107 domain has homology to the cyclin-binding domains of the p21(Waf1/Cip1) family of cyclin-dependent kinase inhibitors (CKIs), we investigated in this study whether B-Myb could also interact with these CKIs. No in vivo interaction was found with either p21(Waf1/Cip1) or p27(KIP1), however, binding to p57(KIP2) was readily detectable in both in vivo and in vitro assays. The B-Myb-interacting region of p57(KIP2) mapped to the cyclin-binding domain. Consistent with this, B-Myb competed with cyclin A2 for binding to p57(KIP2), resulting in release of active cyclin/Cdk2 kinase. Moreover, B-Myb partially overcame the ability of p57(KIP2) to induce G1 arrest in Saos-2 cells. Despite similarities with previous p107 studies, the B-Myb domains required for interaction with p57(KIP2) were quite different from those implicated for p107. Thus, it is evident that B-Myb may promote cell proliferation by a non-transcriptional mechanism that involves release of active cyclin/Cdk2 from p57(KIP2) as well as p107.
- Published
- 2003
21. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex
- Author
-
Joseph B. Rayman, Hein te Riele, Vahan B. Indjeian, Roger J. Watson, Yasuhiko Takahashi, Jan-Hermen Dannenberg, Brian David Dynlacht, and Steven Catchpole
- Subjects
Macromolecular Substances ,Cell Cycle Proteins ,Histone Deacetylase 1 ,Retinoblastoma-Like Protein p107 ,E2F4 Transcription Factor ,Biology ,Retinoblastoma Protein ,Histone Deacetylases ,Mice ,Genetics ,Animals ,Gene Silencing ,E2F ,Promoter Regions, Genetic ,Transcription factor ,E2F4 ,Cells, Cultured ,Regulation of gene expression ,Binding Sites ,Retinoblastoma-Like Protein p130 ,Cell Cycle ,Retinoblastoma protein ,Nuclear Proteins ,Proteins ,Promoter ,Acetylation ,3T3 Cells ,Fibroblasts ,Phosphoproteins ,Molecular biology ,E2F Transcription Factors ,Nucleosomes ,DNA-Binding Proteins ,Repressor Proteins ,embryonic structures ,biology.protein ,biological phenomena, cell phenomena, and immunity ,Corepressor ,Developmental Biology ,Protein Binding ,Transcription Factors ,Research Paper - Abstract
Despite biochemical and genetic data suggesting that E2F and pRB (pocket protein) families regulate transcription via chromatin-modifying factors, the precise mechanisms underlying gene regulation by these protein families have not yet been defined in a physiological setting. In this study, we have investigated promoter occupancy in wild-type and pocket protein-deficient primary cells. We show that corepressor complexes consisting of histone deacetylase (HDAC1) and mSin3B were specifically recruited to endogenous E2F-regulated promoters in quiescent cells. These complexes dissociated from promoters once cells reached late G1, coincident with gene activation. Interestingly, recruitment of HDAC1 complexes to promoters depended absolutely on p107 and p130, and required an intact E2F-binding site. In contrast, mSin3B recruitment to certain promoters did not require p107 or p130, suggesting that recruitment of this corepressor can occur via E2F-dependent and -independent mechanisms. Remarkably, loss of pRB had no effect on HDAC1 or mSin3B recruitment. p107/p130 deficiency triggered a dramatic loss of E2F4 nuclear localization as well as transcriptional derepression, which is suggested by nucleosome mapping studies to be the result of localized hyperacetylation of nucleosomes proximal to E2F-binding sites. Taken together, these findings show that p130 escorts E2F4 into the nucleus and, together with corepressor complexes that contain mSin3B and/or HDAC1, directly represses transcription from target genes as cells withdraw from the cell cycle.
- Published
- 2002
22. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107
- Author
-
Roger J. Watson, Maria Bessa, Mark K Saville, and Manel Joaquin
- Subjects
Transcriptional Activation ,Cancer Research ,animal structures ,Cyclin A ,Molecular Sequence Data ,Cell Cycle Proteins ,Retinoblastoma-Like Protein p107 ,Cyclin-dependent kinase ,Cyclin E ,Genetics ,Tumor Cells, Cultured ,Humans ,Amino Acid Sequence ,Molecular Biology ,Transcription factor ,Binding Sites ,biology ,fungi ,Cyclin-dependent kinase 2 ,G1 Phase ,Nuclear Proteins ,Cell cycle ,Precipitin Tests ,Cell biology ,DNA-Binding Proteins ,embryonic structures ,Cyclin-dependent kinase complex ,biology.protein ,Trans-Activators ,biological phenomena, cell phenomena, and immunity ,E2F Transcription Factors ,Cyclin A2 ,Cell Division ,Protein Binding - Abstract
B-Myb is a cell-cycle regulated transcription factor which is implicated in cell proliferation and has an essential role in early embryonic development. In this study we examined the functions of B-Myb required to overcome G1 arrest in Saos-2 cells induced by the retinoblastoma-related p107 protein. Our results demonstrated that this activity was independent of B-Myb transactivation function, but correlated with its capacity to form an in vivo complex with p107. A large proportion of B-Myb formed complexes with p107 in cotransfected cells, however, B-Myb bound weakly to the related p130 protein and not at all to pRb. In contrast to the E2F transcription factors, which bind the p107 C-terminal pocket domain, B-Myb recognizes an N-terminal p107 region which overlaps the larger cyclin-binding domain. B-Myb and cyclin A2 formed mutually exclusive complexes with p107, and B-Myb enhanced the activity of co-transfected cyclin E kinase activity, implying that B-Myb affects the cell cycle by preventing sequestration of active cyclin/cdk2 complexes. This study defines a novel function of B-Myb and further suggests that the p107 N-terminus provides an interaction domain for transcription factors involved in cell cycle control.
- Published
- 2002
23. A B-myb promoter corepressor site facilitates in vivo occupation of the adjacent E2F site by p107-E2F and p130-E2F complexes
- Author
-
Laurent Le Cam, Claude Sardet, Fiona Tavner, Roger J. Watson, Steven Catchpole, Ludwig Institute for Cancer Research, Imperial College London, Institut de Génétique Moléculaire de Montpellier (IGMM), and Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)
- Subjects
Transcription, Genetic ,Cyclin A ,Repressor ,Cell Cycle Proteins ,Retinoblastoma-Like Protein p107 ,Response Elements ,Retinoblastoma Protein ,Biochemistry ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Genes, Reporter ,Transcription (biology) ,Animals ,Humans ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Promoter Regions, Genetic ,E2F ,Molecular Biology ,Psychological repression ,Cells, Cultured ,030304 developmental biology ,Mice, Knockout ,Oncogene Proteins ,0303 health sciences ,Retinoblastoma-Like Protein p130 ,biology ,Cell Cycle ,Nuclear Proteins ,Proteins ,Promoter ,3T3 Cells ,Cell Biology ,Fibroblasts ,Embryo, Mammalian ,Phosphoproteins ,Molecular biology ,E2F Transcription Factors ,DNA-Binding Proteins ,Repressor Proteins ,030220 oncology & carcinogenesis ,Mutation ,embryonic structures ,Trans-Activators ,biology.protein ,biological phenomena, cell phenomena, and immunity ,Corepressor ,Chromatin immunoprecipitation ,Transcription Factors - Abstract
International audience; Transcription from the B-myb (MybL2 gene) promoter is strictly cell cycle-regulated by repression mediated through an E2F site during G(0)/early G(1). We report here the characterization of a corepressor site (downstream repression site (DRS)) required for this activity that is closely linked to the E2F site. Systematic mutagenesis of the DRS enabled a consensus to be derived, and it is notable that this sequence is compatible with cell cycle gene homology region sequences associated with cell cycle-dependent elements in the cyclin A, cdc2, and CDC25C promoters. The B-myb promoter is inappropriately active during Go in mouse embryo fibroblasts lacking the p107 and p130 pocket proteins, and we show that the ability of transfected p107 and p130 to re-impose repression on the promoter is dependent on the DRS. In contrast, transfected Rb was unable to repress the B-myb promoter. Consistent with the notion that Rb-E2F complexes are unable to bind the B-myb promoter E2F site in vivo, footprinting showed that this site is unoccupied in cells lacking p107 and p130. Chromatin immunoprecipitation assays showed a requirement for the DRS in recruiting p107 and p130 complexes to the B-myb promoter, indicating that in vivo the DRS governs the occupancy of the adjacent E2F site by transcriptional repressors.
- Published
- 2002
24. P0166 Human papillomavirus disrupts P130/dream complexes through different mechanisms
- Author
-
Roger J. Watson, Nurshamimi Nor Rashid, and Rohana Yusof
- Subjects
Cancer Research ,biology ,Mutant ,Cyclin-dependent kinase 2 ,Cell cycle ,Molecular biology ,Cell biology ,Malignant transformation ,Oncology ,Cyclin-dependent kinase ,Cell culture ,embryonic structures ,biology.protein ,Phosphorylation ,DREAM complex ,biological phenomena, cell phenomena, and immunity - Abstract
Background High-risk HPV E6 and E7 oncoprotein expression is important for malignant transformation of cervical cancer cells. In particular, the E7 protein of high-risk HPV binds to pRB family members (pRB, p107, and p130) for degradation. p107 and p130 pocket proteins are members of mammalian DREAM complexes, which are temporally regulated during cell cycle. E7 targets p130 for HPV16 to promote the host cell to exit from quiescence (G 0 ) state and enter S phase. However, p130 is also degraded in HPV48 even though HPV48 E7 does not binding directly to the pocket protein. Therefore we explored the mechanisms responsible for the activities of HPV16 E7 and HPV48 E7 on disruption of p130/DREAM complex. Methods The experiments were done with a p130 mutant that is defective in binding the E7 LXCXE motif (p130mE7) and another mutant that cannot be phosphorylated by CDK (p130PM22). In addition, a double mutant (p130PM22/mE7) was constructed. The p130 mutants and the wild-type p130 were expressed in HPV-transformed cell lines and FACS analysis was done. Subsequently, the T98G glioblastoma cell line was used to ectopically express both HPV16 and 48 with the p130 mutants. Findings The p130mE7 and p130mE7/PM22 mutants prevented the binding of 16E7 in CaSki cells, whereas p130PM22 and p130mE7/PM22 mutants prevented the binding of 48E7 in T98G cells. Interpretation HPV16 E7 targets p130 predominantly through direct interactions via the LXCXE motif whereby HPV48 E7 disrupts p130/DREAM via CDK2 phosphorylation.
- Published
- 2014
25. Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function
- Author
-
Gregory Idos, Sven Diederichs, Wolfgang E. Berdel, Rong Yang, Hubert Serve, Carsten Müller-Tidow, Mark K Saville, H. Phillip Koeffler, Wenbing Wang, Roger J. Watson, and Carol Readhead
- Subjects
Male ,animal structures ,Cyclin E ,Transcription, Genetic ,Macromolecular Substances ,Cyclin D ,Immunology ,Cyclin A ,Cyclin B ,Cell Cycle Proteins ,Protein Serine-Threonine Kinases ,Biochemistry ,Peptide Mapping ,Mice ,Phosphoserine ,Cyclin D1 ,Cyclin-dependent kinase ,CDC2-CDC28 Kinases ,Animals ,Humans ,Phosphorylation ,Promoter Regions, Genetic ,biology ,Cyclin-Dependent Kinase 2 ,Cell Biology ,Hematology ,U937 Cells ,Hematopoietic Stem Cells ,Cyclin-Dependent Kinases ,Cell biology ,DNA-Binding Proteins ,Phosphothreonine ,Gene Expression Regulation ,Organ Specificity ,biology.protein ,Neoplastic Stem Cells ,Trans-Activators ,Cyclin A1 ,Protein Processing, Post-Translational ,Cyclin A2 - Abstract
Cyclin A1 is tissue-specifically expressed during spermatogenesis, but it is also highly expressed in acute myeloid leukemia (AML). Its pathogenetic role in AML and in the cell cycle of leukemic blasts is unknown. B-myb is essential for G1/S transition and has been shown to be phosphorylated by the cyclin A2/cdk2 complex. Here it is demonstrated that cyclin A1 interacts with the C-terminal portion of B-myb as shown by glutathione S-transferase (GST) precipitation. This interaction is confined to cyclin A1 because binding could not be detected between cyclin A2 and B-myb. Also, cdk2 was not pulled down by GST–B-myb from U937 lysates. In addition, co-immunoprecipitation of cyclin A1 and B-myb in leukemic cells evidenced protein interaction in vivo. Baculovirus-expressed cyclin A1/cdk2 complexes were able to phosphorylate human as well as murine B-myb in vitro. Tryptic phosphopeptide mapping revealed that cyclin A1/cdk2 complexes phosphorylated the C-terminal part of B-myb at several sites including threonine 447, 490, and 497 and serine 581. These phosphorylation sites have been demonstrated to be important for the enhancement of B-myb transcriptional activity. Further studies showed that cyclin A1 cooperated with B-myb to transactivate myb binding site containing promoters including the promoter of the human cyclin A1 gene. Taken together, the data suggest that cyclin A1 is a tissue-specific regulator of B-myb function and activates B-myb in leukemic blasts.
- Published
- 2001
26. Three genes with different functions in transformation are regulated by c-Myb in myeloid cells
- Author
-
Linda Wolff, Roger J. Watson, Richard Koller, K Maciag, P Haviernik, Juraj Bies, and M. Schmidt
- Subjects
Myeloid ,Genes, myb ,Genes, myc ,Cell Cycle Proteins ,Biology ,Cell Line ,medicine ,Transcriptional regulation ,Leukocytes ,Animals ,MYB ,Molecular Biology ,Gene ,Transcription factor ,Cyclin-Dependent Kinase Inhibitor p16 ,Cyclin-Dependent Kinase Inhibitor p15 ,Oncogene ,Tumor Suppressor Proteins ,Myeloid leukemia ,Cell Biology ,Hematology ,medicine.disease ,Genes, bcl-2 ,Gene Expression Regulation, Neoplastic ,Leukemia ,medicine.anatomical_structure ,Cell Transformation, Neoplastic ,Cancer research ,Molecular Medicine - Abstract
The proto-oncogene c-myb is constitutively expressed in murine leukemia virus-induced myeloid leukemia (MML) due to the integration of virus at this locus. Our recent focus has been the determination of genes regulated by this transcription factor that may be involved in transformation. Data presented here, using conditional expression of Myb in myeloid cells, show that c-Myb directly transactivates the endogenous c-myc and Bcl-2 genes, which explains at least in part how c-Myb regulates proliferation and survival. In addition, c-Myb prevents expression at the RNA level of the tumor suppressor INK4b gene. This gene encodes a cyclin-dependent kinase inhibitor, p15INK4b, that is normally upregulated at the mRNA level during myeloid differentiation and promotes growth arrest. The MMLs are generally characterized as differentiated monocytic tumors and possess the phenotype that is normally associated with p15INK4b expression. c-Myb inhibits expression of this gene, however, and therefore acts to promote a pathway which is abnormal in mature cells. This activity of c-Myb collaborates with its maintenance of c-myc expression to promote growth.
- Published
- 2001
27. Regulation of the cell cycle by B-Myb
- Author
-
Roger J. Watson, Mark K. Saville, Fiona Tavner, Manel Joaquin, and Maria Bessa
- Subjects
animal structures ,Cyclin A ,Cell Cycle Proteins ,Transfection ,Tumor Cells, Cultured ,E2F1 ,Humans ,MYB ,Molecular Biology ,Transcription factor ,biology ,Cell growth ,fungi ,Cell Cycle ,S-phase-promoting factor ,Cell Biology ,Hematology ,Cell cycle ,Cell biology ,DNA-Binding Proteins ,Gene Expression Regulation ,biology.protein ,Cancer research ,Trans-Activators ,Molecular Medicine ,Restriction point - Abstract
B-Myb is a cell-cycle-regulated member of the Myb transcription factor and, like c-Myb, has been implicated in regulation of hematopoietic cell proliferation and differentiation. In this study we have examined the mechanisms by which B-Myb regulates the cell cycle. We found that the ability of B-Myb both to promote Saos-2 cells into the S phase of the cell cycle and to overcome G1 arrest mediated by overexpression of the retinoblastoma-related p107 protein was correlated with the capacity of B-Myb to form an in vivo complex with p107, but was independent of its transactivation function. Further experiments using a B-Myb dominant-negative protein suggested that transcriptional activation of genes regulated through Myb DNA-binding sequences was required for cell proliferation. Our experiments suggest, therefore, that B-Myb influences cell cycle progression at two distinct levels: by inhibiting p107 and by inducing transcription of specific target genes.
- Published
- 2001
28. Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1
- Author
-
Martino Introna, Fiona Tavner, R Lopa, Roberto Mantovani, Josée Golay, V Facchinetti, F Spreafico, Roger J. Watson, and Fabrizio Bolognese
- Subjects
Cancer Research ,Transcription, Genetic ,Sp1 Transcription Factor ,TATA box ,Molecular Sequence Data ,CAAT box ,Biology ,Regulatory Sequences, Nucleic Acid ,Cell Line ,Exon ,Mice ,Proto-Oncogene Proteins c-myb ,Proto-Oncogene Proteins ,Sequence Homology, Nucleic Acid ,Genetics ,Animals ,Humans ,MYB ,Lymphocytes ,Promoter Regions, Genetic ,Molecular Biology ,Transcription factor ,Binding Sites ,Base Sequence ,Cell Cycle ,Intron ,Promoter ,Molecular biology ,DNA-Binding Proteins ,Gene Expression Regulation ,Regulatory sequence ,CCAAT-Enhancer-Binding Proteins ,Trans-Activators - Abstract
The A-myb transcription factor shows a restricted tissue distribution and is cell cycle regulated. Furthermore its deregulation has profound effects on the growth and/or differentiation of the cells in which it is normally expressed. We have therefore characterized its promoter. A 12 kb genomic clone was isolated that comprises the first exon, part of the first intron as well as upstream regulatory sequences. Multiple transcription start sites have been identified which operate in both B lymphocytes and epithelial cells and the upsteam region was shown to have promoter, activity. The boundaries of the minimal promoter region (−183−14), of a positive upstream (−538−183) and a negative downstream regulatory region (NRE) (+83+374) have been defined. The NRE is promoter- and orientation-independent but position specific. The A-myb minimal promoter is GC-rich, does not contain any TATA box but has a functional CCAAT box. The CCAAT box and minimal promoter is highly conserved in the corresponding murine sequence. The CCAAT box efficiently binds the NF-Y complex and its mutation decreases basal promoter activity by 50%. Two Sp1 binding sites are present upstream from the CCAAT box which can bind Sp1 and contribute to A-myb promoter activity by 70 and 30%, respectively. The two Sp1 sites and CCAAT box together contribute to over 80% of A-myb basal promoter activity and are therefore the major regulatory elements. Finally, we show that the promoter is cell cycle regulated and that the SP1 and CCAAT elements are required for S phase induction.
- Published
- 2000
29. Rapid dephosphorylation of p107 following UV irradiation
- Author
-
J.D. Benett, Roger J. Watson, P.M. Voorhoeve, René Bernards, P.G. Farlie, and Eric Lam
- Subjects
Cyclin-Dependent Kinase Inhibitor p21 ,Cancer Research ,Cell cycle checkpoint ,Ultraviolet Rays ,Phosphatase ,Cell Cycle Proteins ,Retinoblastoma-Like Protein p107 ,Biology ,Cell Line ,Substrate Specificity ,Dephosphorylation ,Mice ,chemistry.chemical_compound ,Cyclins ,Okadaic Acid ,Phosphoprotein Phosphatases ,Tumor Cells, Cultured ,Genetics ,Animals ,Humans ,Protein Phosphatase 2 ,Enzyme Inhibitors ,Phosphorylation ,Oxazoles ,Molecular Biology ,G1 Phase ,Nuclear Proteins ,3T3 Cells ,Protein phosphatase 2 ,Okadaic acid ,Cell cycle ,E2F Transcription Factors ,Cell biology ,DNA-Binding Proteins ,Enzyme Activation ,Biochemistry ,chemistry ,embryonic structures ,Marine Toxins ,Tumor Suppressor Protein p53 ,biological phenomena, cell phenomena, and immunity ,Carrier Proteins ,Transcription Factor DP1 ,G1 phase ,Biologie ,Retinoblastoma-Binding Protein 1 ,Transcription Factors - Abstract
In response to UV irradiation, mouse NIH3T3 fibroblasts transiently arrest predominantly in the G1 phase of the cell cycle. Here, we investigate the role of the retinoblastoma-related pocket proteins in this biological process. We report here that UV induces an increase in p107/E2F complexes, shown previously to be repressors of E2F-dependent transcriptional activity. Several lines of evidence indicate that the increase of p107/E2F complexes following UV irradiation is a consequence of rapid dephosphorylation of p107. First, UV-mediated p107 dephosphorylation could be abolished by pretreatment of NIH3T3 fibroblasts with the serine/threonine phosphatase inhibitors calyculin A and okadaic acid. Second, alteration of protein phosphatase 2A holoenzyme composition by over-expression of specific B subunits interfered with UV-mediated dephosphorylation of p107. Consistent with this, p107 could be dephosphorylated in vitro with PP2A. Moreover, dephosphorylation of p107 was shown to be independent of the activity of p53 and p21, as it occurred also in UV-treated p53-null as well as p21-null mouse fibroblasts. We observed a close correlation between the UV dosages required for G1 cell cycle arrest and p107 dephosphorylation. Our data suggest a model in which UV radiation-induced cell cycle arrest depends, at least in part, on the induction of a PP2A-like phosphatase that acts on p107.
- Published
- 1999
30. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties
- Author
-
Roger J. Watson and Mark K. Saville
- Subjects
Transcriptional Activation ,Cancer Research ,Cyclin E ,Cyclin D ,Recombinant Fusion Proteins ,Cyclin A ,Bone Neoplasms ,Cell Cycle Proteins ,Protein Serine-Threonine Kinases ,Transfection ,S Phase ,Substrate Specificity ,Transactivation ,Phosphoserine ,Structure-Activity Relationship ,Cyclin D1 ,Cyclin-dependent kinase ,Genetics ,CDC2-CDC28 Kinases ,Tumor Cells, Cultured ,Humans ,Phosphorylation ,Molecular Biology ,Osteosarcoma ,biology ,Cyclin-dependent kinase 2 ,Cyclin-Dependent Kinase 2 ,G1 Phase ,Molecular biology ,Cyclin-Dependent Kinases ,DNA-Binding Proteins ,Phosphothreonine ,Gene Expression Regulation ,biology.protein ,Trans-Activators ,biological phenomena, cell phenomena, and immunity ,Protein Processing, Post-Translational ,Cyclin A2 - Abstract
Expression of the B-Myb transcription factor is upregulated during late G1 phase of the cell cycle by an E2F-dependent transcriptional mechanism. B-Myb is specifically phosphorylated during S phase, suggesting that a cyclin-dependent kinase (Cdk) regulates its activity. Consistent with this notion, the S phase-specific cyclin A/Cdk2 was found previously to enhance B-Myb transactivation activity in cotransfected cells. In this study we provide evidence that B-Myb is a direct physiological target for cyclin A/Cdk2. We demonstrate that B-Myb is an in vitro substrate for cyclin A/Cdk2, but not for cyclin D1/Cdk4 or cyclin E/Cdk2. By mutating candidate Cdk2 phosphorylation sites, we show that B-Myb is phosphorylated at Thr447, Thr490, Thr497 and Ser581 by cyclin A/Cdk2 in vitro and that these sites are also phosphorylated in cycling U-2 OS cells. Inhibition of endogenous Cdk2 by dominant negative Cdk2 attenuated phosphorylation of Thr447, Thr490 and Thr497, but had no effect upon Ser581 modification. B-Myb transactivation activity was significantly reduced in a mutant containing amino acid substitutions at all four identified cyclin A/Cdk2 sites and was constitutively low in Saos-2 cells where endogenous cyclin A/Cdk2 activity was unable to phosphorylate ectopically expressed B-Myb. These data indicate that phosphorylation by cyclin A/Cdk2 is directly involved in enhancing B-Myb transactivation activity and that levels of endogenous cyclin A/Cdk2 activity may contribute to cell line-specific B-Myb function.
- Published
- 1998
31. Activation of human B-MYB by cyclins
- Author
-
Cesare Peschle, Roger J. Watson, Ida Casella, Arturo Sala, Marco G. Paggi, Andrew Engelhard, Bruno Calabretta, Mondira Kundu, Luigi Grasso, Kamel Khalili, and Antonio Giordano
- Subjects
Transcriptional Activation ,Cyclin E ,animal structures ,Cyclin D ,Cyclin A ,Cyclin B ,Cell Cycle Proteins ,Cell Line ,Cyclin D1 ,Cyclins ,Humans ,Cyclin B1 ,Phosphorylation ,Multidisciplinary ,biology ,fungi ,Cell Cycle ,Biological Sciences ,Molecular biology ,Cell biology ,DNA-Binding Proteins ,Gene Expression Regulation ,Cyclin-dependent kinase complex ,biology.protein ,Trans-Activators ,Cyclin A2 ,Cell Division ,Transcription Factors - Abstract
B-MYB expression is associated with cell proliferation and recent studies have suggested that it promotes the S phase of mammalian cells. Based on its homology to the transcription factors c-MYB and A-MYB, B-MYB is thought to be involved in transcriptional regulation; however, its activity is not detectable in several cell lines. It was postulated that B-MYB function may depend on the presence of a cofactor, and recent studies suggested that B-MYB is phosphorylated specifically during S phase in murine fibroblasts. In this report we provide evidence that the product of the human B-myb gene can be activated in vivo by coexpression with cyclin A or cyclin E. Transfection studies showed that B-MYB was a weak transcriptional activator in SAOS-2 cells and was unable to promote their proliferation. In contrast, overexpression of both B-MYB and cyclin A or cyclin E caused a drastic increase in the number of SAOS-2 cells in S phase. Also, overexpression of cyclin A and cyclin E in SAOS-2 cells enhanced the ability of B-MYB, but not c-MYB, to transactivate various promoters, including the cdc2 promoter, the HIV-1-LTR, and the simian virus 40 minimal promoter. A direct role for cyclin-dependent activation of B-MYB was demonstrated using an in vitro transcription assay. These observations suggest that one mechanism by which cyclin A and E may promote the S phase is through modification and activation of B-MYB.
- Published
- 1997
32. B-Myb: A Key Regulator of the Cell Cycle
- Author
-
Roger J. Watson and Mark K Saville
- Subjects
Regulation of gene expression ,animal structures ,Cyclin-dependent kinase ,Cell growth ,biology.protein ,MYB ,Cell cycle ,Biology ,E2F ,Cell Cycle Protein ,G1 phase ,Cell biology - Abstract
Publisher Summary The chapter describes that B-Myb gene is subjected to two putative cyclin-dependent regulatory mechanisms during the cell cycle that is upregulation of mRNA abundance by derepression of E2F/DRS-regulated transcription at the G1/S boundary, and phosphorylation of the protein during S phase. This dual mechanism has several features. First, it ensures that in quiescent cells, there is effectively no active B-Myb because transcription is greatly down regulated and the little protein that may be produced is not activated by cyclin-dependent kinases (Cdk)-mediated phosphorylation. Second, it allows for a huge increase in active B-Myb as cells go from the G1 phase into S phase. Third, in cycling cells, the B-Myb produced in S phase may be partially inactivated by dephosphorylation at later stages and only hyperactivated again on entry into the subsequent S phase. The precise role of B-myb in cell cycle regulation is still unknown. B-Myb as a transcriptional activator is foreseen to have function in regulation of other genes whose products are involved in synthesis of the components of nucleotide biosynthesis and DNA replication. As a transcriptional repressor, B-Myb is considered in extinguishing expression of negative regulators of cell proliferation. BMyb has the potential to activate transcription from promoters that lack Myb binding site (MBS), and these genes cannot be predicted from database searches. The realization that B-Myb is subject to controls on both its abundance and activity, that this directs maximal activity to S phase, and that B-Myb function appears to be necessary for cell proliferation leads to conclude that it plays a central role downstream of the cyclins in controlling the basic mechanisms that coordinate passage through the cell cycle.
- Published
- 1997
33. Interference of Myb transactivation activity by a conditional dominant negative protein: functional interference in a cytotoxic T-cell line results in G1 arrest
- Author
-
Roger J. Watson and Jonathan J. Lyon
- Subjects
animal structures ,Transcription, Genetic ,Recombinant Fusion Proteins ,Mice, Transgenic ,Thymus Gland ,Biology ,Transactivation ,Mice ,Proto-Oncogene Proteins c-myb ,Genes, Reporter ,Proto-Oncogene Proteins ,Genetics ,Animals ,MYB ,Cloning, Molecular ,Promoter Regions, Genetic ,Transcription factor ,Interphase ,Cells, Cultured ,Binding Sites ,fungi ,Gene Expression Regulation, Developmental ,General Medicine ,DNA-binding domain ,Cell cycle ,Flow Cytometry ,Fusion protein ,Molecular biology ,Repressor Proteins ,Tamoxifen ,Receptors, Estrogen ,Trans-Activators ,Cell Division ,Binding domain ,Transcription Factors - Abstract
The ability to ablate the activity of specific transcription factors in vivo is a potentially important tool to study their roles in cellular processes such as the cell cycle. Previously, production of a dominant interfering c-Myb protein (comprising a fusion of the c-Myb DNA binding domain with the Drosophila Engrailed transrepressor) was found to inhibit the proliferation of immature thymocytes in the developing thymus of transgenic mice. We report here the further development of this stratagem by rendering the c-Myb/Engrailed protein conditionally active by fusion to a modified estrogen receptor hormone binding domain, ER. Co-transfection experiments in NIH 3T3 fibroblasts showed that the resulting chimeric protein, Myb/En/ER, repressed transactivation of a c-Myb-responsive reporter only in the presence of the synthetic steroid, 4-hydroxytamoxifen (OHT). Additionally, we found that Myb/En/ER could counteract transactivation by C/EBP-beta of the mim-1 promoter, which contains juxtaposed Myb and C/EBP binding sites. Cytotoxic T-cells stably producing the inactive Myb/En/ER protein were readily obtained by gene transfection. The addition of OHT to these cells resulted in inhibition of proliferation and arrest in G1. The utility of this experimental system to study Myb and other transcription factors is discussed.
- Published
- 1996
34. B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells
- Author
-
Roger J. Watson, Arturo Sala, Ida Casella, Bruno Calabretta, Teresa Bellon, and Cesare Peschle
- Subjects
Transcription, Genetic ,Cellular differentiation ,Retinoblastoma-Like Protein p107 ,Cell Cycle Proteins ,Biochemistry ,Retinoblastoma Protein ,S Phase ,Transactivation ,Mice ,Tumor Cells, Cultured ,Homeostasis ,Luciferases ,Osteosarcoma ,Nuclear Proteins/metabolism ,RB ,biology ,Cell Cycle ,Retinoblastoma protein ,Nuclear Proteins ,Transfection ,Adenovirus E2 Proteins ,Recombinant Proteins ,Cell biology ,DNA-Binding Proteins ,Gene Expression Regulation, Neoplastic ,Cell Division ,Plasmids ,DNA Replication ,Transcriptional Activation ,animal structures ,Cell Survival ,Bone Neoplasms ,Cell Line ,Animals ,Humans ,Molecular Biology ,Gene ,DNA synthesis ,Cell growth ,fungi ,Cell Biology ,Oncogenes ,Kinetics ,Cell culture ,biology.protein ,Trans-Activators ,Glioblastoma ,Transcription Factors - Abstract
The retinoblastoma protein family has been implicated in growth control and modulation of the activity of genes involved in cell proliferation, such as B-myb. Recent evidence indicates that the product of the B-myb gene is necessary for the growth and survival of several human and murine cell lines. Upon overexpression, B-myb induces deregulated cell growth of certain cell lines. Here we show that B-myb overexpression is able to induce DNA synthesis in p107 growth-arrested human osteosarcoma cells (SAOS2). p107 might exert its growth-suppressive activity by regulating B-myb gene transcription. Indeed, p107 down-modulated B-myb promoter activity and drastically decreased E2F-mediated transactivation. Finally, B-myb was able to stimulate DNA synthesis of both stably and transiently transfected human glioblastoma cells (T98G). Altogether, these data provide definitive evidence that the human B-myb protein is involved in growth control of human cells, and that p107 has a significant role in regulating B-myb gene activity.
- Published
- 1996
35. Cell-cycle regulation of human B-myb transcription
- Author
-
Eric Lam, Julie D. Bennett, and Roger J. Watson
- Subjects
Keratinocytes ,Transcription, Genetic ,Recombinant Fusion Proteins ,Response element ,Molecular Sequence Data ,Cell Cycle Proteins ,Resting Phase, Cell Cycle ,S Phase ,Mice ,Sp3 transcription factor ,Sequence Homology, Nucleic Acid ,Genetics ,E2F1 ,Animals ,Humans ,E2F ,Promoter Regions, Genetic ,Transcription factor ,Phylogeny ,Cell Line, Transformed ,General transcription factor ,biology ,Base Sequence ,Cell Cycle ,Retinoblastoma protein ,Promoter ,General Medicine ,3T3 Cells ,Molecular biology ,E2F Transcription Factors ,DNA-Binding Proteins ,Gene Expression Regulation ,biology.protein ,Trans-Activators ,biological phenomena, cell phenomena, and immunity ,Carrier Proteins ,Sequence Alignment ,Transcription Factor DP1 ,Retinoblastoma-Binding Protein 1 ,Transcription Factors - Abstract
We demonstrate here that activity of the human B-myb promoter is regulated during the cell cycle by the E2 transcription factor (E2F). Comparison of the human B-myb promoter sequence with that of its murine counterpart revealed an evolutionally conserved sequence that contains an E2F-binding site. In transiently transfected murine NIH3T3 and human HaCaT cells, luciferase (Luc) reporter activity directed by the human B-myb promoter was found to increase significantly in late G1/S phase of the cell cycle. Mutation of the promoter E2F site resulted in significantly greater Luc activity in NIH3T3 and HaCaT cells made quiescent by serum deprivation, indicating that E2F repressed transcription of this gene during G0. Analysis of E2F DNA-binding activity in G0 HaCaT cells revealed a distinct complex that apparently contained neither the retinoblastoma gene protein, pRb, nor the related p107 protein. De-repression of transcription in S phase was accompanied by the disappearance of this G0 E2F complex and the appearance of a distinct complex containing p107. In addition, complexes containing pRb were detected at both stages of the cell cycle.
- Published
- 1995
36. HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes
- Author
-
Karen H. Vousden, Eric Lam, Tim Crook, Roger J. Watson, Rachel Davies, and J. D. H. Morris
- Subjects
Keratinocytes ,Transcriptional Activation ,Papillomavirus E7 Proteins ,Molecular Sequence Data ,Cell Cycle Proteins ,Retinoblastoma-Like Protein p107 ,Biology ,General Biochemistry, Genetics and Molecular Biology ,3T3 cells ,Transactivation ,Mice ,Cyclins ,medicine ,Animals ,Humans ,Cell Cycle Protein ,E2F ,Promoter Regions, Genetic ,Molecular Biology ,Transcription factor ,Cell Line, Transformed ,General Immunology and Microbiology ,Base Sequence ,General Neuroscience ,G1 Phase ,Nuclear Proteins ,Proteins ,3T3 Cells ,Oncogene Proteins, Viral ,Cell cycle ,Molecular biology ,E2F Transcription Factors ,DNA-Binding Proteins ,medicine.anatomical_structure ,Oligodeoxyribonucleotides ,Trans-Activators ,biological phenomena, cell phenomena, and immunity ,Carrier Proteins ,Transcription Factor DP1 ,Research Article ,Retinoblastoma-Binding Protein 1 ,Transcription Factors - Abstract
HPV16 is a human tumour virus encoding two principal oncoproteins, E6 and E7. Expression of E7 can induce DNA synthesis in quiescent cells and this property coincides with its ability to bind to the cell proteins pRb and p107. As these cell proteins are regulators of the transcription factor E2F, we have investigated whether the interaction with E7 could result in induction of cell cycle regulated genes. We show that B-myb, whose induction at the G1/S boundary is regulated by release from E2F mediated transcriptional repression, is a target for transcriptional activation by E7 and is the first E7 responsive cell gene to be identified. E7 transactivation leads to both inappropriate transcription of B-myb during G1 and constitutive over-expression in cycling cells. B-Myb plays an essential role in cell cycle progression, and activation by E7 is likely to contribute to the mitogenic activity of the viral oncoprotein. Regulation of the B-myb promoter in NIH3T3 cells correlates with binding of distinct p107-containing complexes at the E2F binding site, and analysis of E7 mutants confirms that B-myb transcription in these cells is regulated through interactions with p107 rather than pRb. These results provide the first example of a potentially specific role for p107 in the regulation of the cell cycle.
- Published
- 1994
37. Transcription regulation by murine B-myb is distinct from that by c-myb
- Author
-
C. Robinson, Roger J. Watson, and Eric Lam
- Subjects
Transcriptional Activation ,animal structures ,Saccharomyces cerevisiae Proteins ,Transcription, Genetic ,Response element ,Molecular Sequence Data ,Genes, myc ,Cell Cycle Proteins ,Simian virus 40 ,Biology ,Fungal Proteins ,Upstream activating sequence ,Mice ,Proto-Oncogene Proteins c-myb ,Transcription (biology) ,Proto-Oncogene Proteins ,Genetics ,Animals ,Humans ,MYB ,Cloning, Molecular ,Promoter Regions, Genetic ,Transcription factor ,Regulation of gene expression ,Binding Sites ,Base Sequence ,fungi ,Promoter ,3T3 Cells ,DNA ,Molecular biology ,DNA-Binding Proteins ,Gene Expression Regulation ,Trans-Activators ,Electrophoresis, Polyacrylamide Gel ,Transcription Factors - Abstract
The transcription regulatory properties of murine B-myb protein were compared to those of c-myb. Whereas c-Myb trans-activated an SV40 early promoter containing multiple copies of an upstream c-Myb DNA-binding site (MBS-1), and similarly the human c-myc promoter, B-Myb was unable to do so. Full-length B-Myb translated in vitro did not bind MBS-1; however, truncation of the B-Myb C-terminus or fusion of the B-Myb DNA-binding domain to the c-Myb C-terminus showed that it was inherently competent to interact with this motif. Further evidence from co-transfection experiments, demonstrating that B-Myb inhibited trans-activation by c-Myb, suggested that failure of B-Myb to trans-activate these promoters did not simply occur through lack of binding to MBS-1. Moreover, using GAL4/B-Myb fusions, it was found that an acidic region of B-Myb, which by comparison to c-Myb was expected to contain a transcription activation domain, actually had no inherent trans-activation activity and indeed appeared to trans-inhibit c-Myb. In contrast to the above findings, both B-Myb and c-Myb were able to weakly trans-activate the DNA polymerase alpha promoter. Results obtained here demonstrate that the activities of B-Myb and c-Myb are clearly distinct and suggest that these related proteins may have different functions in regulation of target gene expression.
- Published
- 1993
38. Characterization of transcription-deficient temperature-sensitive mutants of herpes simplex virus type 1
- Author
-
Roger J. Watson and J. Barklie Clements
- Subjects
Transcription, Genetic ,Mutant ,Temperature ,Nucleic Acid Hybridization ,RNA ,Biology ,medicine.disease_cause ,Molecular biology ,Virus ,Cell Line ,Complementation ,Viral Proteins ,chemistry.chemical_compound ,Herpes simplex virus ,chemistry ,Transcription (biology) ,Virology ,Mutation ,medicine ,Protein biosynthesis ,RNA, Viral ,Simplexvirus ,DNA - Abstract
Six DNA-negative, temperature-sensitive ( ts ) mutants ( ts B, ts D, ts E, ts K, ts S, and ts T) of herpes simplex virus type 1, which fall into four complementation groups, have been characterized by analyses of the nuclear and cytoplasmic transcripts synthesized in cells infected at the restrictive temperature. Transcripts were hybridized to blot strips containing the separated fragments of virus DNA generated by digestion with restriction endonucleases Hin d III, Hpa I, or Bam H1. The hybridization patterns thus obtained have been compared with the patterns given by RNA isolated from cells infected with wild-type virus and labeled at early and late times postinfection (before and after viral DNA replication), or in the continuous presence of inhibitors of DNA or protein synthesis (Clements, J. B., Watson, R. J., and Wilkie, N. M. (1977). Cell 12 , 275–285). Of these mutants, ts K is the most restricted in transcription and gives a pattern of hybridization similar to that observed with immediate-early RNA (transcribed in the absence of protein synthesis). Two mutants ( ts D and ts T), which lie in a different complementation group to ts K, also give restricted hybridization patterns but express additional regions of the genome as compared with ts K RNA. Inasmuch as these three mutants fall into two complementation groups, these experiments suggest that at least two viral products are required to progress from the immediate-early to the early stage of transcription. The hybridization patterns obtained with the other early mutants examined here ( ts B, ts E, and ts S) are, in contrast, much less restricted, and resemble the early, rather than late pattern. Downshift of ts K-infected cells from the nonpermissive to the permissive temperature, both in the presence and absence of further protein synthesis, results in the transcription of regions which map throughout the viral genome. These experiments suggest, therefore, that the polypeptides which are required for the switch-on of these additional transcripts accumulate in ts K-infected cells under restrictive conditions.
- Published
- 1978
39. The uptake of phenylalanine and tyrosine by seedling root tips
- Author
-
Leslie Fowden and Roger J. Watson
- Subjects
biology ,Phenylalanine ,Plant Science ,General Medicine ,Horticulture ,biology.organism_classification ,Biochemistry ,Non-competitive inhibition ,Seedling ,Botany ,Caesalpinia ,Tyrosine ,Molecular Biology ,Cucumis - Abstract
The uptake of phenylalanine and tyrosine into seedling root tips of Cucumis melo and Caesalpinia tinctoria depended on coexisting metabolic and non-metabolic processes. Competitive inhibition studies and kinetic experiments indicated that a single active uptake system operated for all α-amino acids. This active uptake system is compared to those occurring in other types of organism, and the possible role of cation-exchange uptake is discussed. 3-Hydroxymethylphenylalanine and 4-hydroxy-3-hydroxymethylphenylalanine, natural products of Caesalpinia tinctoria , inhibited phenylalanine uptake more in Cucumis than in Caesalpinia .
- Published
- 1975
40. Herpes Simplex Virus Type-1 Glycoprotein D Gene: Nucleotide Sequence and Expression inEscherichia coli
- Author
-
John S. Salstrom, Lynn W. Enquist, J H Weis, and Roger J. Watson
- Subjects
Genes, Viral ,viruses ,Protein Sorting Signals ,medicine.disease_cause ,Virus ,Viral Proteins ,Plasmid ,Escherichia coli ,medicine ,Simplexvirus ,Amino Acid Sequence ,Antigens, Viral ,Peptide sequence ,Gene ,Glycoproteins ,chemistry.chemical_classification ,Multidisciplinary ,Base Sequence ,Nucleic acid sequence ,Viral Vaccines ,Virology ,Molecular biology ,Herpes simplex virus ,Gene Expression Regulation ,Genes ,chemistry ,Peptides ,Glycoprotein - Abstract
The protein coding region of the herpes simplex virus type-1 glycoprotein D (gD) gene was mapped, and the nucleotide sequence was determined. The predicted amino acid sequence of the gD polypeptide was found to contain a number of features in common with other virus glycoproteins. Insertion of this protein coding region into a bacterial expressor plasmid enabled synthesis in Escherichia coli of an immunoreactive gD-related polypeptide. The potential of this system for preparation of a type-common herpes simplex virus vaccine is discussed.
- Published
- 1982
41. The activation of amino acid analogues by phenylalanyl- and tyrosyl-tRNA synthetases from plants
- Author
-
Leslie Fowden, Roger J. Watson, and Roger D. Norris
- Subjects
chemistry.chemical_classification ,Natural product ,biology ,Stereochemistry ,Substrate (chemistry) ,Plant Science ,General Medicine ,Horticulture ,biology.organism_classification ,Biochemistry ,Amino acid ,chemistry.chemical_compound ,chemistry ,Transfer RNA ,Substrate specificity ,Phaseolus ,Caesalpinia ,Molecular Biology ,Delonix regia - Abstract
Partially purified preparations of Phe- and Tyr- t RNA synthetases were obtained from seed or seedlings of Phaseolus aureus , Delonix regia and Caesalpinia tinctoria , and the ability of a variety of structural analogues of Phe or Tyr to act as alternative substrates or inhibitors was tested. 3-Hydroxymethylphenylalanine, a natural product of C. tinctoria , formed a particularly effective substrate for the Tyr- t RNA synthetase from P. aureus . The structural features commensurate with substrate activity in an analogue molecule are discussed.
- Published
- 1975
42. DNA sequence of the Herpes simplex virus type 2 glycoprotein D gene
- Author
-
Roger J. Watson
- Subjects
Genetics ,Base Sequence ,Genes, Viral ,viruses ,Nucleic acid sequence ,General Medicine ,Biology ,medicine.disease_cause ,Molecular biology ,Conserved sequence ,Single-stranded binding protein ,Viral Proteins ,Herpes simplex virus ,Species Specificity ,Viral Envelope Proteins ,Regulatory sequence ,medicine ,biology.protein ,Simplexvirus ,Coding region ,Amino Acid Sequence ,Gene ,Peptide sequence ,Glycoproteins - Abstract
We describe a 1635-bp Herpes simplex virus type 2 (HSV-2) DNA sequence containing the entire coding region of glycoprotein D (gD-2). The amino acid sequence of gD-2, deduced from the nucleotide sequence, was compared to that of the analogous Herpes simplex virus type 1 (HSV-1) glycoprotein (gD-1). The two glycoproteins are 85% homologous and contain highly conserved regions of as much as 49 amino acids in length. Comparison of DNA sequences upstream from gD-1 and gD-2 coding regions identified possible conserved regulatory sequences.
- Published
- 1983
43. Control of Herpes Simplex Virus Transcription
- Author
-
J. Barklie Clements and Roger J. Watson
- Subjects
Base Sequence ,Genes, Viral ,Transcription, Genetic ,DNA-Directed RNA Polymerases ,Biology ,medicine.disease_cause ,Biochemistry ,Virology ,Molecular Weight ,Herpes simplex virus ,Transcription (biology) ,Mutation ,medicine ,RNA ,Simplexvirus - Published
- 1978
44. Down-regulation of c-myb gene expression is a prerequisite for erythropoietin-induced erythroid differentiation
- Author
-
Kazuo Todokoro, Hiroshi Amanuma, Hiromi Yanagisawa, Hiromi Higo, Yoji Ikawa, Roger J. Watson, and Satomi Kuramochi
- Subjects
Transcription, Genetic ,Cellular differentiation ,Biology ,Transfection ,Cell Line ,Gene product ,Mice ,hemic and lymphatic diseases ,Proto-Oncogenes ,Gene expression ,Animals ,MYB ,RNA, Messenger ,Erythropoietin ,Regulation of gene expression ,Leukemia, Experimental ,Multidisciplinary ,Oncogene ,fungi ,Cell Differentiation ,DNA, Neoplasm ,MRNA stabilization ,Molecular biology ,Gene Expression Regulation ,Leukemia, Erythroblastic, Acute ,DNA Probes ,Half-Life ,Research Article - Abstract
The role of nuclear protooncogenes during erythroid cell differentiation was examined by transfecting exogenous c-fos and c-myb genes into mouse erythroleukemia cells, which can be induced to differentiate either with erythropoietin (Epo) or dimethyl sulfoxide. Expression of exogenous c-myb or c-fos oncogene completely inhibited Epo-induced erythroid differentiation but only partially inhibited dimethyl sulfoxide-induced differentiation. Normally Epo-induced differentiation leads to a drastic decline of c-myb mRNA levels and an increase of c-myc transcripts in the early stage of differentiation. Cells expressing exogenous c-fos gene, however, maintained high levels of c-myb mRNA after Epo treatment. This high level of c-myb transcripts was found to be due to block of transcription shutoff (or transcriptional activation) rather than to mRNA stabilization. It is concluded that the down-regulation of endogenous c-myb gene expression is a prerequisite for commitment of Epo-induced erythroid differentiation and that expression of c-myb gene may be indirectly regulated by c-fos gene product. We also concluded that early down-regulation of c-myc gene expression is not essential for erythroid differentiation and that gene regulation of chemically induced erythroid differentiation may differ from that of Epo-induced differentiation.
- Published
- 1988
45. A Bacteriophage λ cI857 Cassette Controls λ PL Expression Vectors at Physiologic Temperatures
- Author
-
Roger J. Watson, Douglas F. Harbrecht, Henry Joseph George, and William J. DeLorbe
- Subjects
Expression vector ,biology ,Biomedical Engineering ,Repressor ,Bioengineering ,medicine.disease_cause ,biology.organism_classification ,Applied Microbiology and Biotechnology ,Molecular biology ,Bacteriophage ,Plasmid ,Lysogen ,Gene expression ,medicine ,Molecular Medicine ,Gene ,Escherichia coli ,Biotechnology - Abstract
We have developed a cassette of the bacteriophage lambda (λ) cI857 temperature–sensitive repressor gene from which the functional PR promoter has been deleted. This cassette was placed into an expression vector that uses the PL promoter for expression of the herpes simplex virus type 1 (HSV–1) glycoprotein D gene (gD–1) in E. coli. Control of the gD–1 production from this plasmid was compared to an expression vector lacking the cI857 cassette but regulated by an E. coli (cI857) lysogen. The lysogen allowed expression of the gD–1 gene at 37°C, whereas cells containing the cI857 cassette maintained repression of gD–1. Both systems were fully induced at 42°C. The ability to grow cells at 37°C while maintaining repression of transcription from PL should be advantageous for large scale fermentations.
- Published
- 1987
46. Characterization of the herpes simplex virus type 1 glycoprotein D mRNA and expression of this protein in Xenopus oocytes
- Author
-
Lynn W. Enquist, Roger J. Watson, Anamaris M. Colberg-Poley, Barrie J. Carter, and Carol J. Marcus-Sekura
- Subjects
Genes, Viral ,Transcription, Genetic ,Xenopus ,viruses ,Cycloheximide ,Biology ,medicine.disease_cause ,Cell Line ,Viral Proteins ,chemistry.chemical_compound ,Viral Envelope Proteins ,Chlorocebus aethiops ,Genetics ,medicine ,Protein biosynthesis ,Animals ,Simplexvirus ,Coding region ,RNA, Messenger ,Gene ,Messenger RNA ,Base Sequence ,Cytarabine ,biology.organism_classification ,Molecular biology ,Molecular Weight ,Herpes simplex virus ,Genes ,chemistry ,Protein Biosynthesis ,Oocytes ,Vero cell ,Female - Abstract
We have identified and characterized a 3.0 kilobase (kb) mRNA containing coding sequences of the herpes simplex virus type 1 (HSV-1) glycoprotein D (gD) gene. The synthesis of this 3.0 kb mRNA was unaffected by the presence of cytosine arabinoside, but was made in greatly reduced amounts in cells infected with HSV-1 in the presence of cycloheximide: it was, therefore, classified as an early mRNA. By nuclease protection experiments, it was found that the 3.0 kb mRNA is unspliced and, further, that it is 3' co-terminal with a smaller 1.6 kb early mRNA which is transcribed from a DNA sequence 3' to the gD coding sequence. We describe the use of the Xenopus laevis oocyte system to produce HSV-1 gD in vitro. Oocytes injected with mRNA isolated from HSV-1-infected Vero cells synthesized gD, which was identified by immunoprecipitation. Injection of a plasmid clone containing the HSV-1 BamHI J fragment (0.89 to 0.93 map units) into the nuclei of Xenopus oocytes also resulted in synthesis of gD.
- Published
- 1983
47. Amino acids of Caesalpinia tinctoria and some allied species
- Author
-
Leslie Fowden and Roger J. Watson
- Subjects
chemistry.chemical_classification ,Imino acid ,biology ,food and beverages ,Plant Science ,General Medicine ,Horticulture ,biology.organism_classification ,Biochemistry ,Amino acid ,chemistry ,Chemotaxonomy ,Botany ,Caesalpinia ,Amino acid content ,Caesalpinioideae ,Molecular Biology - Abstract
Two previously unreported amino acids have been found to form major constituents of seed of Caesalpinia tinctoria ; they have been characterized as 4-hydroxy-3-hydroxymethylphenylalanine and 3-hydroxymethylphenylalanine. The seed also contains a large amount of the imino acid baikiain. The amino acid content of seeds of this species is compared with that for 12 other species of Caesalpinia and 14 species in closely related genera.
- Published
- 1973
48. Reiterated sequences within the intron of an immediate-early gene of herpes simplex virus type 1
- Author
-
Roger J. Watson, Lynn W. Enquist, and Kenichi Umene
- Subjects
Genetics ,Nuclease ,Genes, Viral ,Base pair ,Nucleic acid sequence ,Intron ,DNA Restriction Enzymes ,Biology ,medicine.disease_cause ,Molecular biology ,Herpes simplex virus ,Tandem repeat ,Complementary DNA ,DNA, Viral ,medicine ,biology.protein ,RNA, Viral ,Simplexvirus ,RNA, Messenger ,Cloning, Molecular ,Gene ,Research Article ,Repetitive Sequences, Nucleic Acid - Abstract
We describe the nucleotide sequence of a herpes simplex virus type 1 DNA fragment containing the intron of the immediate-early mRNA-5 (IE mRNA-5) gene. The location of the intron within this fragment was determined by a Berk & Sharp nuclease S1 protection analysis, and by cloning and sequencing cDNA containing sequences overlapping t he IE mRNA-5 splice point. We found that the 149 base pair (bp) intron contained four copies of an identical 23 bp GC rich tandem repeat followed by a further reiteration consisting of the first 15 bp only.
- Published
- 1981
49. Tandem repeated DNA in an intergenic region of herpes simplex virus type 1 (Patton)
- Author
-
K. Umene, Roger J. Watson, and Lynn W. Enquist
- Subjects
Transcription, Genetic ,EcoRI ,DNA, Recombinant ,Biology ,medicine.disease_cause ,Restriction fragment ,chemistry.chemical_compound ,Intergenic region ,Tandem repeat ,Genetics ,medicine ,Simplexvirus ,Cloning, Molecular ,Gene ,Repetitive Sequences, Nucleic Acid ,Base Sequence ,General Medicine ,DNA Restriction Enzymes ,Molecular biology ,Herpes simplex virus ,chemistry ,DNA, Viral ,biology.protein ,BamHI ,DNA - Abstract
When the entire Us region of HSV-1 (Patton) was cloned as an EcoRI fragment in bacteriophage λgtWES, the BamHI B6B5 fragment was observed to vary in size among independent isolates [Umene and Enquist, Gene 13 (1981) 251–268]. This fragment polymorphism also occurred in DNA of HSV-1 single plaque isolates. We report here that this heterogeneity is due to variation in copy number of a 15-bp tandem repeat of sequence 5'-CCACTCCCCACCCAC-3', which apparently lies in an intergenic region of the HSV-1 DNA.
- Published
- 1984
50. An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D
- Author
-
Roger J. Watson, J H Weis, Lynn W. Enquist, and John S. Salstrom
- Subjects
viruses ,medicine.disease_cause ,Virus ,Single-stranded binding protein ,Viral Proteins ,Viral Envelope Proteins ,medicine ,Escherichia coli ,Simplexvirus ,Antigens, Viral ,Infectivity ,chemistry.chemical_classification ,Multidisciplinary ,biology ,Chemistry ,Viral Vaccines ,beta-Galactosidase ,Herpesvirus glycoprotein B ,Virology ,Bacteriophage lambda ,Herpes simplex virus ,biology.protein ,Antibody ,Glycoprotein ,Genetic Engineering ,Plasmids - Abstract
Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) cause both persistent and latent infections, including recurrent cutaneous disease, lethal neonatal disease, central nervous system disease and other clinical syndromes. Modified live vaccines or conventionally prepared subunit vaccines have generally been unsuccessful in the treatment of HSV-1 and HSV-2 infections from the standpoints of safety and efficacy. It has been established that HSV-1 and HSV-2 infectivity may be neutralized in vitro with antisera directed specifically against each of the four major glycoproteins of the virus (gA/gB, gC, gD and gE) and antisera against glycoprotein gD, of either HSV-1 or HSV-2, are capable of neutralizing both HSV-1 and HSV-2 infectivity in vitro and in vivo. We have previously reported on the identification, DNA sequence and expression at low level in Escherichia coli of the gD gene of HSV-1 strain Patton. Here we describe construction of a hybrid gene encoding a chimaeric protein containing HSV-1 gD, bacteriophage lambda Cro and E. coli beta-galactosidase (gD-beta-gal) protein, which is expressed at high level in E. coli. Moreover, the chimaeric protein elicits antibodies in rabbits that not only immunoprecipitate gD from cells infected with HSV-1 and HSV-2 but also neutralize HSV-1 and HSV-2 infectivity in vitro.
- Published
- 1983
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.